Pharmacovigilance Solutions

PV & safety teams are charged with ensuring adherence to regulatory and legal policies while putting patient safety above all else. TransPerfect supports these efforts with technology and services that help pharma, biotech, and med device companies ensure the safety of their patients by accelerating the time to report safety cases. 

Get in Touch
Clinician using clipboard to mark off drug information

24/7 Support to Ensure Patient Safety Anytime, Anywhere

With the varying and often strict ICSR reporting timelines, it is imperative that serious adverse events (SAEs) are reported quickly to mitigate any potential harm to patients involved in trials. Our end-to-end services, paired with AI and technology for translation, help to reduce timelines for reporting events to the regulatory committees and ensure patient safety.

Why PV & Safety Teams Love TransPerfect

Our knowledge and experience in pharmacovigilance is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

Literature Search

Improve your multilingual literature monitoring process with our comprehensive solution, which enables the collation, search, delivery, and translation of local and international literature (published and scientific) for adverse events.

Learn More ›

Call Center Support

Field non-English SA/SAE reporting with our world-class call center support division, TP Connect. With more than 100 global offices, we have helped many pharma companies quickly report and act on adverse events called in all over the world.

Learn More ›

AI Portal for Case Triage

Automate your translation process for faster turnaround times while also enabling your case processor to quickly prioritize incoming reports based on seriousness across 200+ languages.

Learn More ›

Language/Translation Solutions

Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

Learn More ›

Training & Development

Whether your needs are temporary or ongoing, we help PV & safety teams select, test, train, and onboard multilingual staff to support outbound patient surveillance calls. Ensure your staff is trained with localized content and training materials for international markets, hosted in a 21 CFR Part 11 data room capable of generating reports on compliance.

Learn More ›

eClinical

Maintain compliance and enhance patient safety with the Trial Interactive PMSF solution. An easy-to-use, web-based format, our technology solution traffics safety notifications and distributes alerts in real time, ensuring that sites, sponsors, and CROs remain fully apprised of the latest information and data to meet good pharmacovigilance practices (GVP) and, of course, patient safety standards.

Learn More ›

Redaction

All safety reports contain personally identifiable information (PII) of patients. Protect patient safety and privacy with our redaction services prior to regulatory review.

Learn More ›

Medical Writing

When it comes to creating, managing, and translating safety content, medical writers play an integral role in protecting patient safety and adhering to strict regulations within tight deadlines. Our team of expert medical writers has in-depth knowledge of best practices for drafting and maintaining safety content, including PSURs/PBRERs, DSURs, RMPs, and more.

Learn More ›

Social Media Monitoring

Enhance patients’ real-world usage and feedback, including detecting potential adverse events, with multilingual social media monitoring.

Learn more ›

Trusted by Life Sciences Organizations Big and Small

BMS
Chiesi
Biogen
Fulgent
Innovaderm
Johnson & Johnson logo
NIH
Novartis
Paraxel
Pfizer logo
Roche logo
Sanofi logo

News and Press Releases

Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

The C3 Summit: Boston Recap

The second event in our series of C3 Summits took place in Boston on May 16, 2023. We invited industry experts and leaders to discuss challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments through the lens of real-world experience. In this recap of the Boston session, we will review key points from each session.  Session 1: COA/eCOA Innovations – Licensing Hiccups, Linguistic Validation, ePRO Migration, and Best ...

The C3 Summit: Boston Recap

How Medical Writing Can Drive Patient Engagement

Medical writing is a critical component of the broader patient engagement landscape, establishing the foundations of communication between pharmaceutical companies and patients. The quality of medical communication can be transformational in how a patient engages with and...

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & ...

Navigating the EU Clinical Trial Regulation Complexities - Current Challenges and Opportunities

As the most significant change in the European Union clinical trial legislative ecosystem in 20 years, the European Union Clinical Trial Regulation 536/2014 (EU CTR) went live on January 31, 2022. The first-year transition period has now ended, and from January 31, 2023, EU ...

How to Maximise Value and Avoid Failure During Life Sciences Dealmaking

Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices ...

Centralizing Global Content Solutions for Medical Affairs

With a rapidly evolving landscape and the introduction of new technologies and emerging therapeutics, medical affairs professionals are tasked with remaining in lockstep with the latest industry developments. From a content perspective, this means not only maintaining clear...

Automation for MDR & IVDR: A Three-Part Seminar - Part 3: EnCompass Step by Step: A Detailed View of the Content Automation Solution to Meet MDR & IVDR Requirements

Part 3: EnCompass Step by Step: A Detailed View of the Content Automation Solution to Meet MDR & IVDR Requirements ...

Talk to Us About Your Global PV and Safety Programs.

Get a free consultation. 

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.